CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell TherapiesJesse Green, Terry J. Fry, Adam Johnson et al.|Blood|2022Cited by 5
Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell TherapyAdam Johnson, Terry J. Fry, Sam Crocker et al.|Blood|2023Cited by 4
Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma PatientsJeremy M. Kinder, Terry J. Fry, Chanel Athena Estrada et al.|Blood|2023Cited by 3
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell TherapyVandana Chaturvedi, Terry J. Fry, Jesse Green et al.|Blood|2023Cited by 3
<i>In Vitro and In Vivo</i> Specificity and Biodistribution of a Novel CD8-Targeted FusosomeHemantkumar Chavan, Sundeep Chandra, Shirisha Amatya et al.|Blood|2023Cited by 2